Related Experiment Videos
Cough is an airway itch?
American Journal of Respiratory and Critical Care Medicine
|December 26, 2003
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Safety of the 6-min walk test in adults with severe asthma.
Respiratory medicine·2025
Infant respiratory outcomes following asthma management and exacerbations in pregnancy.
ERJ open research·2025
Evaluation of the effect of multimorbidity on difficult-to-treat asthma using a novel score (MiDAS): a multinational study of asthma cohorts.
The Lancet. Respiratory medicine·2025
Digitally mapping the asthma journey-from diagnosis to remission.
EClinicalMedicine·2025
Impact of clinical remission on quality of life in severe eosinophilic asthma treated with mepolizumab.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2025
Acute exacerbation in fibrotic interstitial lung disease: An International Working Group Report.
American journal of respiratory and critical care medicine·2026
Peripubertal Changes in Asthma.
American journal of respiratory and critical care medicine·2026
Incretins Predict Response to Enteral Nutrition Strategies in the EDEN Trial: A Secondary Analysis.
American journal of respiratory and critical care medicine·2026
Nutrition and Exercise in Critical Illness (NEXIS) trial: randomized trial of combined in-bed cycling and intravenous amino acid plus usual care.
American journal of respiratory and critical care medicine·2026
Residual disease activity in cystic fibrosis lung disease: implications for clinical management and research.
American journal of respiratory and critical care medicine·2026
Mycophenolate and Azathioprine in Fibrotic Interstitial Lung Disease.
American journal of respiratory and critical care medicine·2026
Upadacitinib for refractory generalized lichen sclerosus: a case report and brief literature review.
Frontiers in immunology·2026
Case Report: A case report of bullous pemphigoid triggered by sintilimab (PD-1 inhibitor).
Frontiers in immunology·2026